Prospective, Open-Label, Multi-Center, Phase III Clinica

Project: Research project

Description

Prospective, Open-Label, Multi-Center, Phase III Clinical Study To Investigate the Efficacy And Safety of Human Factor VWF/VIII Concentrate (Wilate)In Subjects With Inherited Type 3 Von Willebrand Disease (VWD) Who Undergo Major Surgical Procedures
StatusFinished
Effective start/end date3/14/123/13/17

Funding

  • OCTAPHARMA USA, INC.

Fingerprint

Type 3 Von Willebrand's Disease
Factor VIII
Safety
Clinical Studies
human F8 protein